Research improving breast cancer treatment by targeting tumor initiating cells
Wednesday February 13, 2013
A Kansas State University professor’s research on breast cancer stem cells may help improve survival rates by preventing cancer recurrence and metastasis — the major causes of death among breast cancer patients.
Anna Zolkiewska, associate professor of biochemistry and molecular biophysics, has received a four-year $1.245 million grant from the National Cancer Institute — at the National Institutes of Health — to study a promising breast cancer marker called ADAM12. The grant is titled “ADAM12 in breast tumor initiating cells.
Read the whole story.